SAN DIEGO, CA--(Marketwired - Apr 20, 2017) - MyDx, Inc. (OTCQB: MYDX), a rapidly growing science and technology company that has developed MyDx®, the first multi-use handheld chemical analyzer for consumers, today released its 2016 fiscal year earnings call results and management analysis presentation.
FY2016 EARNINGS CALL PRESENTATION
Please click here to access the presentation:
FY2016 EARNINGS CALL DETAILS
(Press/ Media and the public are encouraged to participate)
A conference call with CEO Daniel Yazbeck and the investor community is scheduled as follows:
Date & time: Thursday, April 20, 2017 at 10:00 a.m. (PDT)/ 1:00 p.m. (EDT)
Registration is required for online and telephone access.
Please call in 5 minutes prior to the call, so that the call can begin promptly.
- Business highlights and company performance, including record revenue & EBITDA growth
- MyDx robust standing and performance relative to industry peers
- The power of data and its transformative capabilities
- The path forward to unlocking shareholder value and maximizing returns
We are excited and there is a lot of advancements we will be covering. We ask that the Q&A be focused on the 2016 results and our business development efforts as outlined in our presentation. We will do our best to address every question.
We appreciate all of your support and thank you in advance for your participation.
About MyDx, Inc.
MyDx, Inc. (OTCQB: MYDX) is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust & Verify® what they put into their minds and bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user's hand. The multi-use MyDx analyzer leverages over a decade of established chemical detection technology to measure chemicals of interest. The Company owns a substantial and growing intellectual property portfolio of patents covering its technology. The MyDx AquaDx®, OrganaDx™ and CannaDx™ sensors are now commercialized, and the AeroDx® application is next in line. All sensors will be compatible with a MyDx App that empowers consumers to live a healthier life by revealing the chemical composition of what they eat, drink and inhale. For more information, please visit www.cdxlife.com.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at http://ir.cdxlife.com/all-sec-filings or www.sec.gov.